SHPH Projected Dividend Yield
Com (NEW)/Shuttle Pharmaceuticals Holdings Inc ( NASDAQ : SHPH )Shuttle Pharmaceuticals Holdings, Inc. is a discovery and development stage specialty pharmaceutical company. Co. is focused on improving the outcomes of cancer patients treated with radiation therapy (RT). It is developing a pipeline of products designed to address cancer therapies as well as to extend to the new applications of radiation therapy. Its product candidates include Ropidoxuridine (IPdR), Ropidoxuridine and Tipracil (IPdR/TPI), SP-1-161, SP-2-225, and SP-1-303. Ropidoxuridine (IPdR) is its lead candidate radiation sensitizer for use in combination with RT to treat brain tumors (glioblastoma) and sarcomas. 21 YEAR PERFORMANCE RESULTS |
SHPH Dividend History Detail SHPH Dividend News SHPH Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |